Prospective signs of cleidocranial dysplasia in Cebpb deficiency

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Huang, Boyen ^a,b   Takahashi, Katsu ^b   Jennings, Ernest A ^a   Pumtang On, Pongthorn ^c   Kiso, Honoka ^b   Togo, Yumiko ^b   Saito, Kazuyuki ^b   Sugai, Manabu ^d   Akira, Shizuo ^e   Shimizu, Akira ^d   Bessho, Kazuhisa ^b  

^a JAMES COOK UNIVERSITY   (Australia)

^b KYOTO UNIVERSITY   (Japan)

^c Setthasiri Animal Hospital   (Thailand)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Cebpb; Clavicle; Cleidocranial dysplasia; Masseter; Temporal muscle; Thoracic cage; Zygomatic arch

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CEBPB PROTEIN, MOUSE; RUNX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RUNX2;

ADULT; ANATOMIC LANDMARK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE CONTROL STUDY; CCAAT ENHANCER BINDING PROTEIN BETA DEFICIENCY; CLAVICLE; CLEIDOCRANIAL DYSPLASIA; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; DISEASE ASSOCIATION; ETIOLOGY; FEMALE; GEOMETRY; MALE; MASSETER MUSCLE; MASTICATORY MUSCLE; MICRO-COMPUTED TOMOGRAPHY; MORPHOLOGY; MOUSE; MURINE MODEL; MUSCULOSKELETAL DEVELOPMENT; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETON; TEMPORALIS MUSCLE; X RAY; X RAY SYSTEM; ZYGOMA; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MISSENSE MUTATION; PATHOLOGY; SKULL;

MUS;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CLEIDOCRANIAL DYSPLASIA; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MUSCULOSKELETAL DEVELOPMENT; MUTATION, MISSENSE; PHENOTYPE; SKULL;

EID: 84901750757     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-44     Document Type: Article

References (37)

1. Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia. Suda N, Hattori M, Kosaki K, Banshodani A, Kozai K, Tanimoto K, Moriyama K, Orthod Craniofac Res 2010 13 197 202 10.1111/j.1601-6343.2010.01495.x 21040462
2. Cleidocranial dysplasia: a rare case associated with congenital hypothyroidism and severe neonatal hyperbilirubinemia. Chen BH, Chen LY, Jaw TH, Chao MC, Kaohsiung J Med Sci 1998 14 53 57 9519691
3. Cleidocranial dysplasia: radiological appearances on dental panoramic radiography. McNamara CM, O'Riordan BC, Blake M, Sandy JR, Dentomaxillofac Radiol 1999 28 89 97 10.1038/sj.dmfr.4600417 10522197
4. Morphologic characteristics of masseter muscle in cleidocranial dysplasia: a report of 3 cases. Furuuchi T, Kochi S, Sasano T, Iikubo M, Komai S, Igari K, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 99 185 190 10.1016/j.tripleo.2004.03.011 15660090
5. Cleidocranial dysplasia-a case report. Rizvi S, Raihan H, Rizvi T, Biomed Res 2006 17 129 132
6. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR, Cell 1997 89 773 779 10.1016/S0092-8674(00)80260-3 9182765
7. Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation. Liu JC, Lengner CJ, Gaur T, Lou Y, Hussain S, Jones MD, Borodic B, Colby JL, Steinman HA, van Wijnen AJ, Stein JL, Jones SN, Stein GS, Lian JB, J Biol Chem 2011 286 30057 30070 10.1074/jbc.M111.241505 21676869
8. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, Cell 1997 89 747 754 10.1016/S0092-8674(00)80257-3 9182762
9. Formation of oral and pharyngeal dentition in teleosts depends on differential recruitment of retinoic acid signaling. Gibert Y, Bernard L, Debiais-Thibaud M, Bourrat F, Joly J-S, Pottin K, Meyer A, Retaux S, Stock DW, Jackman WR, Seritrakul P, Begemann G, Laudet V, FASEB J 2010 24 3298 3309 10.1096/fj.09-147488 20445074
10. Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. Åberg T, Wang X-P, Kim J-H, Yamashiro T, Bei M, Rice R, Ryoo HM, Thesleff I, Dev Biol 2004 270 76 93 10.1016/j.ydbio.2004.02.012 15136142
11. FGF2 Stimulation of the pyrophosphate-generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2. Hatch NE, Li Y, Franceschi RT, J Bone Miner Res 2009 24 652 662 10.1359/jbmr.081213 19049325
12. Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. Diehl AM, J Biol Chem 1998 273 30843 30846 10.1074/jbc.273.47.30843 9812973
13. C/EBPβ, but not C/EBP, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ, Rosen JM, Genes Dev 1998 12 1917 1928 10.1101/gad.12.12.1917 9637692
14. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. Poli V, J Biol Chem 1998 273 29279 29282 10.1074/jbc.273.45.29279 9792624
15. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Cell 1995 80 353 361 10.1016/0092-8674(95)90418-2 7530603
16. Complex regulation of the fibroblast growth factor-binding protein in MDA-MB-468 breast cancer cells by CCAAT/enhancer-binding protein β Kagan BL, Henke RT, Cabal-Manzano R, Stoica GE, Nguyen Q, Wellstein A, Riegel AT, Cancer Res 2003 63 1696 1705 12670924
17. CCAAT/enhancer-binding protein β is required for mitotic clonal expansion during adipogenesis. Tang Q-Q, Otto TC, Lane MD, Proc Natl Acad Sci U S A 2003 100 850 855 10.1073/pnas.0337434100 12525691
18. CCAAT/enhancer binding protein β abrogates retinoic acid-induced osteoblast differentiation via repression of Runx2 Transcription. Wiper-Bergeron N, St-Louis C, Lee JM, Mol Endocrinol 2007 21 2124 2135 10.1210/me.2006-0452 17579210
19. CCAAT/enhancer-binding protein β promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Tominaga H, Maeda S, Hayashi M, Takeda S, Akira S, Komiya S, Nakamura T, Akiyama H, Imamura T, Mol Biol Cell 2008 19 5373 5386 10.1091/mbc.E08-03-0329 18843047
20. C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2 as the inducer in chondrocytes. Hirata M, Kugimiya F, Fukai A, Saito T, Yano F, Ikeda T, Mabuchi A, Sapkota BR, Akune T, Nishida N, Yoshimura N, Nakagawa T, Tokunaga K, Nakamura K, Chung UI, Kawaguchi H, Hum Mol Genet 2012 21 1111 1123 10.1093/hmg/ddr540 22095691
21. CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. Gutierrez S, Javed A, Tennant DK, van Rees M, Montecino M, Stein GS, Stein JL, Lian JB, J Biol Chem 2002 277 1316 1323 10.1074/jbc.M106611200 11668178
22. Mandibular phenotype of p20C/EBPβ transgenic mice: reduced alveolar bone mass and site-specific dentin dysplasia. Savage T, Bennett T, Huang YF, Kelly PL, Durant NE, Adams DJ, Mina M, Harrison JR, Bone 2006 39 552 564 10.1016/j.bone.2006.01.164 16682266
23. Phenotypes of CCAAT/enhancer-binding protein beta deficiency: hyperdontia and elongated coronoid process. Huang B, Takahashi K, Sakata-Goto T, Kiso H, Togo Y, Saito K, Tsukamoto H, Sugai M, Akira S, Shimizu A, Bessho K, Oral Dis 2013 19 144 150 22849712
24. Impaired postnatal development in C/EBP beta deficient mice. Bai T, Tanaka T, Yukawa K, Umesaki N, Matsumoto M, Akira S, J Reprod Dev 2006 52 645 649 10.1262/jrd.17093 16837772
25. Parallels of craniofacial maldevelopment in down syndrome and Ts65Dn mice. Richtsmeier JT, Baxter LL, Reeves RH, Dev Dyn 2000 217 137 145 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N 10706138
26. Measurement of the maxilla and zygoma as an aid in installing zygomatic implants. Uchida Y, Goto M, Katsuki T, Akiyoshi T, J Oral Maxillofac Surg 2001 59 1193 1198 10.1053/joms.2001.26725 11573181
27. Cook M, The Anatomy of the Laboratory Mouse New York: Academic 1 1965
28. Sidebotham TH, The A to Z of Mathematics: A Basic Guide Hoboken, NJ: Wiley 2003
29. The influence of masticatory hypofunction on developing rat craniofacial structure. Tsai CY, Yang LY, Chen KT, Chiu WC, Int J Oral Maxillofac Surg 2010 39 593 598 10.1016/j.ijom.2010.02.011 20219321
30. Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo. Salingcarnboriboon R, Tsuji K, Komori T, Nakashima K, Ezura Y, Noda M, Endocrinology 2006 147 2296 2305 10.1210/en.2005-1020 16455780
31. Hzf regulates adipogenesis through translational control of C/EBP alpha. Kawagishi H, Wakoh T, Uno H, Maruyama M, Moriya A, Morikawa S, Okano H, Sherr CJ, Takagi M, Sugimoto M, EMBO J 2008 27 1481 1490 18418387
32. Control selection for RNA quantitation. Suzuki T, Higgins PJ, Crawford DR, Biotechniques 2000 29 332 337 10948434
33. Altman D, Practical Statistics for Medical Research London: Chapman and Hall 1991
34. Patterns of asymmetry in primary tooth emergence of Australian twins. Mihailidis S, Woodroffe SN, Hughes TE, Bockmann MR, Townsend GC, Front Oral Biol 2009 13 110 115 19828980
35. Forensic age estimation on digital x-ray images: medial epiphyses of the clavicle and first rib ossification in relation to chronological age. Garamendi PM, Landa MI, Botella MC, Alemán I, J Forensic Sci 2011 56 3 S12 21155800
36. Dubrul E, Sicher and Dubrul's Oral Anatomy Ishiyaku Euroamerica: St. Louis 8 1988
37. Adaptation of the masseter and temporalis muscles following alteration in length, with or without surgical detachment. Maxwell L, Carlson D, McNamara JJ, Faulkner J, Anat Rec 1981 200 127 137 10.1002/ar.1092000203 6455941